Navigation Links
Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
Date:12/16/2009

LAKE FOREST, Ill., Dec. 16 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its fourth-quarter and full-year 2009 results and projections for 2010 on Thursday, Feb. 4, 2010, at 8 a.m. Central time.

The company will release its fourth-quarter and full-year 2009 results earlier that morning, before the U.S. stock market open and the conference call.

A live webcast of the conference call will be available on Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the webcast. A replay will be available on the Hospira Web site for 30 days following the call.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness((TM)). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.

SOURCE Hospira, Inc.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
2. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
3. Hospira Reports Third-Quarter 2009 Results
4. Hospira Names Daphne E. Jones Chief Information Officer
5. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
6. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
7. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
8. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
9. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call
11. Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe ... Italy , UK, Spain ) Summary GBI ... Europe ( Germany , France , ... analysis of the transcatheter heart valves market in Europe . ... period and key company share data by revenue in 2013 for the following ...
(Date:9/23/2014)... -- Report Details Where is the prostate cancer ... potential revenues to 2024, assessing data, trends, opportunities and ... charts, and graphs. Our new study lets you assess ... market, showing their prospects to 2024. Discover the most ... prospects. Our new study lets you assess forecasted sales ...
(Date:9/23/2014)... , Sept. 23, 2014  SI-BONE, Inc., a medical ... Implant System, ® a minimally invasive surgical (MIS) ... today announced that the U.S. Patent and Trademark Office ... and methods for the fixation and fusion of bone.  ... implant with a tapered distal end that may be placed from one ...
Breaking Medicine Technology:Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) 2The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies 2The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies 3The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies 4The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies 5SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3
... a biotechnology company that develops targeted therapies for oncology ... results from studies of TRC105 and TRC102 in patients ... Society of Clinical Oncology annual meeting this May 28th ... pathways with the potential for broad application to a ...
... Confirm Tapentadol Efficacy and Tolerability for Acute Pain PatientsRARITAN, ... to 30 percent of all people who have surgery ... The use of opioid pain medicines during and after ... side effects. Nausea and vomiting are uncomfortable and bothersome ...
Cached Medicine Technology:TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8
(Date:9/23/2014)... Oakland, California (PRWEB) September 23, 2014 ... knows everything about cultivating, growing and harvesting marijuana. He ... innovators in the field and he’ll be leading a ... from 10:00 am to 5:00 pm at Oaksterdam ... cover cultivation law, botany and nomenclature, harvesting and manicuring, ...
(Date:9/23/2014)... ZEPHYRHILLS, FL (PRWEB) September 23, 2014 ... opening of the newly renovated Women’s Health Center ... square feet of space, the specially designed center ... women in East Pasco County. The Women’s Health ... and pelvic floor health, labor and delivery through ...
(Date:9/23/2014)... TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF OPIOIDS ... WHAT: , The National Institutes of Health is convening ... scientific evidence on the long-term effectiveness and potential risks ... among the nation,s top experts in the field of ... well as key NIH scientists who focus on pain ...
(Date:9/23/2014)... September 24, 2014 From first-hand experience, ... (PTSD) – and how it can be treated. , ... in Iraq in 2006. His platoon sustained multiple attacks ... he was diagnosed with combat-related PTSD and honorably discharged ... angry, and I had distanced myself from my friends ...
(Date:9/23/2014)... Dr. Connie Casad has announced that she will be ... at 12200 Park Central Drive, Suite 200, Dallas, Texas 75251 ... Cities Aesthetics, Optimal Health and Wellness, her gynecology practice and ... Casad said, “The patients’ comfort and satisfaction are our primary ... to always feel like their needs are valued and recognized ...
Breaking Medicine News(10 mins):Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Dr. Connie Casad Moving to New Office Location 2
... month long fund raising events to find the cure, ... officially declared November as Tay-Sachs Awareness Month,and encourages all ... the need for research to help find a cure. ... frequently in Ashkenazi Jews, French,Canadians, Louisiana Cajuns, and Irish ...
... breakdown, in the epidermis , , FRIDAY, Nov. 2 (Health ... the biological mechanism by which stress increases susceptibility to ... the basis of the stress," said study author Dr. ... of California, San Francisco, and the VA Medical Center, ...
... Mammography Van Features ... NovationDR Digital System, MALVERN, Pa., Nov. 2 ... digital mammography,system in the U.S. The MAMMOMAT(R) NovationDR, a ... Nevada Cancer Institute,s,(NVCI) new Hope Coach, a mobile digital ...
... Emotional Intelligence could be defined as the capacity to perceive, ... so as to be able to distinguish between emotions and ... actions. One of the important benefits of developing this type ... with others and to face an ever changing social and ...
... LAUREL, N.J., Nov. 2 MedQuist Inc. (Pink,Sheets: MEDQ) ... its,previously-disclosed review of strategic alternatives for the Company, is,evaluating ... best interests of the,Company and its shareholders, in light ... ("Philips") of its decision to proceed,with the sale of ...
... Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today ... designation awarded to PI-88 for the,prevention of tumour ... in order to commence the Phase 3 program ... continue with the Special Protocol,Assessment process. The ...
Cached Medicine News:Health News:Governor Strickland Declares November Tay-Sachs Awareness Month 2Health News:Governor Strickland Declares November Tay-Sachs Awareness Month 3Health News:Stress Robs Skin of Antimicrobial Defenses 2Health News:Siemens Rolls Out Its First Mobile Digital Mammography System in the U.S. 2Health News:Siemens Rolls Out Its First Mobile Digital Mammography System in the U.S. 3Health News:Emotional Intelligence and the use of tobacco and cannabis 2Health News:MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Shareholders 2Health News:Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer 2Health News:Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: